Heat therapy for lung cancer: early trial ends early
NCT ID NCT04889989
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at using a microwave ablation device to destroy lung tumors in people who could not have surgery or chose not to. It included 13 adults with non-small cell lung cancer or tumors that had spread to the lung. The treatment was given through a needle inserted into the chest. The study was stopped early, so the results are not conclusive.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
microwave ablation (a device that uses heat to destroy tumors)
What this could lead to
If successful, this approach could offer a less invasive option for people with lung cancer who cannot undergo surgery.
What could go wrong
The study was terminated early and enrolled only 13 people, so results are very limited. Microwave ablation may not fully destroy all tumor cells, and risks include bleeding or damage to nearby tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Hospital
Beijing, China
-
Fudan University Shanghai Cancer Hospital
Shanghai, China
-
Henan Cancer Hospital
Henan, China
-
Hunan Cancer Hospital
Hunan, China
-
Pecking University Shenzhen Hospital
Beijing, China
-
Qilu Hospital of Shandong University
Shandong, China
-
The First Affiliated Hospital of Fujian Medical University
Fujian, China
-
The Fourth Affiliated Hospital of Harbin Medical University
Harbin, China